Hypersensitivity to the active substance or to any of the excipients listed in Description.
Concomitant use of other soluble guanylate cyclase (sGC) stimulators, such as riociguat (see Interactions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education